DROSERA ROTUNDIFOLIA (HOMEOLAB USA INC.)
Welcome to the PulseAid listing for the DROSERA ROTUNDIFOLIA drug offered from HOMEOLAB USA INC.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | HOMEOLAB USA INC. |
NON-PROPRIETARY NAME: | DROSERA ROTUNDIFOLIA |
SUBSTANCE NAME: | DROSERA ROTUNDIFOLIA |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | PELLET |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2013-11-18 |
END MARKETING DATE: | 0000-00-00 |
DROSERA ROTUNDIFOLIA HUMAN OTC DRUG Details:
Item Description | DROSERA ROTUNDIFOLIA from HOMEOLAB USA INC. |
LABELER NAME: | HOMEOLAB USA INC. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1([hp_X]/1) |
START MARKETING DATE: | 2013-11-18 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 60512-1015_7baaa926-234f-488a-983e-e11c8758d6b8 |
PRODUCT NDC: | 60512-1015 |
APPLICATION NUMBER: | |
Other DROSERA ROTUNDIFOLIA Pharmaceutical Manufacturers / Labelers: